In 2002, we decided to re-invent how central laboratory solutions were delivered. We could create a new industry standard built on agility, customization, and client-centricity. And we did just that.

We learned that sponsors were concerned about the quality of collection kits, the accuracy and timeliness of their data, the reliability of logistics, and the responsiveness of central laboratory project management and client services teams. We believed we could create a new industry standard by developing robust solutions to mitigate these concerns.

We set out to build an agile, client-centric model focused on customization with the goal of being the central laboratory of choice for sponsors and sites by delivering exceptional service, industry-leading collection kits, and tailored solutions for our clients' most complex needs.

This period saw the global expansion of clinical trials beyond North America and Western Europe into Eastern Europe, Latin America, India, and Australia. Our agile operating model enabled rapid growth in these regions, supporting trials with laboratories and regional teams in these emerging centers of patient recruitment.

As time passed, demand for molecular diagnostics grew for patient screening and efficacy assessment, and we rose to the challenge, continuously connecting the dots.

“We soon realized we were creating a truly unique central laboratory services delivery model. One that went beyond bricks and mortar, one that was a flexible network of innovative labs and services, meeting the demands of a rapidly evolving world.”

Our service portfolio began to grow, assisting clients with navigating the new analytical requirements, combining central laboratory solutions with scientific consultancy and functional outsourcing, and creating an entirely new dimension of support and connection. Our experts in these specialized services began guiding clients throughout their entire drug development cycle, ensuring optimized study designs from the very start.

A new era of clinical research was beginning.

Technological progression and clinical trial design were creating advances in medicine at a rapid pace. We recognized these changes early on, and another goal was reached by foreseeing the future complex needs of clients through a set of services, uniquely positioning us as the lab of choice.

“The operational, analytical and logistical challenges and complexities associated with executing modern trials have increased by 61% in the past two decades. And it will continue.” 1

Anticipating the need for better sample tracking, we became the first central lab to introduce technologies for investigative sites that are now widely adopted. Today, as our proprietary sample tracking systems evolve, we remain technology agnostic, partnering with leading AI-powered tools to stay in front.

Due to the number of specialized labs utilized per study increasing simultaneously with geographical diversity, logistical complexity rose disproportionately to all other aspects of trial delivery. To address this challenge, we formed unique partnerships with our specialized and routine logistics providers to facilitate seamless, worldwide execution of shipping requirements.

Since our inception, we have been recognized as the leader in site-friendly collection supplies, hand-building customized kits that are easy to use and mitigate potential errors, more important than ever during this era of complexity.

Recognizing and understanding the demand for advanced laboratory technologies to detect subtle changes missed by less sensitive methods, we built a global network of clinical and specialty laboratories.

Advanced analytical methods often dictate that specialized samples are processed within tight timelines and according to exacting protocols.

Our Global Sample Processing Network (GSPN) has over 30 qualified global locations to support PBMC isolations, RNA/DNA extractions, and CtDNA preparation services. We actively monitor the performance to ensure that lab, site and transport issues are addressed in a proactive manner.

We anticipated that laboratory data points would expand with the growth of precision medicine and biomarker research. Additionally, decentralization and continued challenges in patient recruitment and retention means that it's not just the volume of data, but also where it is coming from.

Wearable devices and intelligent technology are transforming our space, generating unprecedented levels of pre-screening and continuous monitoring, and this is why we are laser-focused on data management and transformation, regardless of its source.

We recognized the need for a new level of data integration, harmonization, and standardization to manage and understand the overwhelming lab-based and digital volume. We re-imagined data delivery as a unified set, ensuring clarity and integrity, our model has proven this and continues to drive the industry's evolution.

Powered by flexibility, streamlined operations and strategic alliances, we are strategically positioned to support global studies of any scale, providing:

custom lab kit design and build
advanced sample tracking
integrated logistics
industry-leading testing menu
worldwide radiopharmaceuticals support
next-generation biorepository services

“For over 20 years, the analytical, operational, and logistical requirements of sponsors have evolved, and our operating model has become a perfect fit. So much so, it has fueled our growth, and we are now recognized as being a world leader in our industry.”

Many things have changed along the way, but we have always maintained our belief that a focus on exceptional client service and unparalleled flexibility in a world of complexity is the key to success.

A belief that consulting with clients and guiding them from the beginning and throughout the drug development cycle would take a new way of operating. It did, it still does, and it's why we do things the way we do. Our model is all about:

future and flexibility
success and scalability
advancement and agility

We made plans based on these pillars from the very beginning, plans that saw us set the wheels in motion, backed by the vision and the bravery to activate them.

We continue to connect clinical trials with our technology-driven, customized, orchestrated, and scalable support services, and in doing so, we have helped lead the evolution of central laboratory services for global clinical trials.

So, when it comes to planning your study's success, ask us, because we have the answers. But it's bigger than that. For you to move forward with integrity and clarity, it's not just about us having the answers; it's about being the answer.

And we are.

We are LabConnect.
We are your answer to advance.

1. Saama technologies. eBook: Data Volume, Complexity, Cost: Current Challenges in Clinical Trials.
2. Tufts Center for Drug Development. Rising Protocol Design Complexity Is Driving Rapid Growth in Clinical Trial Data Volume. January/February 2021. Vol. 23 No. 1.